You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Neoplasms, Plasma Cell

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Myeloma, Primary Plasma Cell Leukemia Trial in Shanghai (Experimental: CAR-T cells Infusion)

Not yet recruiting
  • Multiple Myeloma
  • Primary Plasma Cell Leukemia
  • Experimental: CAR-T cells Infusion
  • Shanghai, China
    Shanghai Changzheng Hospital
Apr 20, 2023

Multiple Myeloma, Plasma Cell Leukemia Trial in Suzhou (CT0594CP)

Recruiting
  • Multiple Myeloma
  • Plasma Cell Leukemia
  • CT0594CP
  • Suzhou, Jiangsu, China
    First Affiliated Hospital, Soochow University
Apr 18, 2023

Relapsed and/or Refractory Multiple Myeloma, Plasma Cell Leukemia in Relapse Trial in Shanghai (Biological)

Recruiting
  • Relapsed and/or Refractory Multiple Myeloma
  • Plasma Cell Leukemia in Relapse
  • Biological
  • Shanghai, Shanghai, China
    Shanghai Tongji Hospital
May 29, 2023

Relapsed/Refractory Multiple Myeloma, Plasma Cell Leukemia Trial (CAR-T (CAR-GPRC5D))

Not yet recruiting
  • Relapsed/Refractory Multiple Myeloma
  • Plasma Cell Leukemia
  • CAR-T (CAR-GPRC5D)
  • (no location specified)
Feb 26, 2023

Multiple Myeloma, Plasma Cell Leukemia Trial in Shanghai (Human BCMA targeted CAR-NK cells injection)

Recruiting
  • Multiple Myeloma
  • Plasma Cell Leukemia
  • Human BCMA targeted CAR-NK cells injection
  • Shanghai, Shanghai, China
    Shanghai Changzheng Hospital
Sep 13, 2023

Myeloma Multiple Trial (Off Drug Surveillance)

Not yet recruiting
  • Myeloma Multiple
  • Off Drug Surveillance
  • (no location specified)
Jun 27, 2023

Multiple Myeloma, Lymphoma, Engagement, Patient Trial (Grastofil®, Lapelga)

Not yet recruiting
  • Multiple Myeloma
  • +3 more
  • (no location specified)
Oct 30, 2023

Examination of Trends in Multiple Myeloma Trial Patient

Not yet recruiting
  • Multiple Myeloma
    • (no location specified)
    May 19, 2023

    Multiple Myeloma Prognostic Indices

    Recruiting
    • Multiple Myeloma
    • Hematologic Diseases
    • blood viscosity , albumin / fibrinogen ratio and red cell distribution
    • Assiut, Egypt
      Assiut University hospital
    Oct 17, 2023

    Relapsed/Refractory Multiple Myeloma Trial in Philadelphia (Cevostamab)

    Not yet recruiting
    • Relapsed/Refractory Multiple Myeloma
    • Philadelphia, Pennsylvania
      Hospital of the University of Pennsylvania
    Apr 7, 2023

    New Echocardiographic Indicators in Treatment of Primary

    Not yet recruiting
    • Multiple Myeloma
    • Chemotherapy and/or autologous hematopoietic stem cell transplantation
    • (no location specified)
    Sep 18, 2023

    Multiple Myeloma, Fatigue, Pain Trial (Auricular Acupuncture)

    Not yet recruiting
    • Multiple Myeloma
    • +3 more
    • Auricular Acupuncture
    • (no location specified)
    Mar 7, 2023

    Multiple Myeloma, Primary Plasma Cell Leukemia, Extramedullary Multiple Myeloma Trial in Wuhan (Daratumumab, Carfilzomib,

    Recruiting
    • Multiple Myeloma
    • +2 more
    • Wuhan, Hubei, China
      Institute of Hematology, Union Hospital, Tongji Medical College,
    Nov 18, 2023

    Myeloma Multiple Trial in Chia (Dasatinib 100 MG)

    Not yet recruiting
    • Myeloma Multiple
    • Dasatinib 100 MG
    • Chia, Cundinamarca, Colombia
      CAIMED
    Jul 12, 2023

    Multiple Myeloma Trial (Teclistamab, Tocilizumab)

    Not yet recruiting
    • Multiple Myeloma
    • (no location specified)
    Jul 24, 2023

    Multiple Myeloma Trial in Los Angeles (Penguin Cold Cap)

    Recruiting
    • Multiple Myeloma
    • Penguin Cold Cap
    • Los Angeles, California
      Cedars-Sinai Medical Center
    Jul 27, 2023

    Alvocade® (Bortezomib) Safety and Effectiveness Study

    Completed
    • Multiple Myeloma, Refractory
    • (no location specified)
    Aug 19, 2023

    Multiple Myeloma Trial (Iberdomide, Daratumumab/rHuPH20 Co-formulation)

    Not yet recruiting
    • Multiple Myeloma
    • (no location specified)
    Oct 25, 2023

    Real-World Mapping Antithrombotic Regimens in MM Patients on

    Not yet recruiting
    • Multiple Myeloma
    • Diagnosis
      • (no location specified)
      Aug 31, 2023

      Lymphoma, Multiple Myeloma Trial in Chongqing (pegylated recombinant human granulocyte-colony stimulating factor)

      Recruiting
      • Lymphoma
      • Multiple Myeloma
      • pegylated recombinant human granulocyte-colony stimulating factor
      • Chongqing, Chongqing, China
        Chongqing University Cancer Hospital
      Sep 23, 2023

      Multiple Myeloma Trial in São Paulo (Single-dose involved-site radiotherapy)

      Recruiting
      • Multiple Myeloma
      • Single-dose involved-site radiotherapy
      • São Paulo, Sao Paulo, Brazil
        University of Sao Paulo
      Aug 9, 2023

      Multiple Myeloma Trial in Wuhan (Total Marrow irradiation,TMI, Autologous hematopoietic stem cell transplantation)

      Recruiting
      • Multiple Myeloma
      • Total Marrow irradiation，TMI
      • Autologous hematopoietic stem cell transplantation
      • Wuhan, Hubei, China
        Zhongnan Hospital of Wuhan University
      Jul 24, 2023

      Laboratory Biomarkers in Elderly Patients With Multiple Myeloma

      Recruiting
      • Plasma Cell Myeloma
      • Biospecimen Collection
      • +3 more
      • Rochester, Minnesota
        Mayo Clinic in Rochester
      Jun 26, 2023

      Learn How Triple Class Refractory Multiple Myeloma Are Treated

      Not yet recruiting
      • Relapse Multiple Myeloma
      • Refractory Multiple Myeloma
        • (no location specified)
        Feb 15, 2023

        Multiple Myeloma Trial (Patient Reported Outcomes)

        Not yet recruiting
        • Multiple Myeloma
        • Patient Reported Outcomes
        • (no location specified)
        Apr 24, 2023